Oct 2026· Reactions weekly· Vol 2131, pp. 110 - 110· 0 citations
TL;DR
How reliance on blast morphology alone in this context could be misleading is illustrated and the importance of integrating flow cytometry with other laboratory modalities to classify such complex malignancies and guide subsequent therapy is highlighted, highlighting therapy-related leukaemogenesis in survivors of this malignancy.
POEMS syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, Skin changes) is an orphan multisystem plasma cell dyscrasia-associated disease. It is challenging to diagnose because not all of the five signs included in this acronym may be evident on initial presentation. The diagnosis of POEMS syndrome is ju...
S. V. Semochkin, V. Lunin, A. Grachev et al.· Clinical oncohematology· 0 citations
A 69-year-old female with newly diagnosed MLNFGFR1 in blast phase, presenting with concurrent myeloproliferative neoplasm and T-lymphoblastic lymphoma remains in complete remission at 17 months after pemigatinib initiation, with treatment-related toxicity being manageable through dose modifications and temporary interr...
C. Stafylidis, E. Variami, E. Lakiotaki et al.· Leukemia and Lymphoma· 0 citations
Acute lymphoblastic leukemia (ALL) following lenalidomide (LEN) therapy is rare. A 64-year-old man developed myelodysplastic syndrome with excess blasts-2 (MDS-EB-2) six years after LEN maintenance therapy following autologous stem cell transplantation for multiple myeloma, followed by Philadelphia chromosome-negative...
Background: Chronic lymphocytic leukemia (CLL) presents a very high clinical-biological heterogeneity, and the therapeutic choice depends on several parameters, primarily the evolutionary stage of the disease and the presence of molecular anomalies such as the 17p deletion. We report the case of a patient with CLL for...
K. Bouzenda, Rym Gourmat, A. Zidani et al.· International Journal of Dru...· 0 citations
Aggressive natural killer-cell leukemia (ANKL) is an exceedingly rare and rapidly fatal malignancy of mature NK cells, frequently associated with Epstein-Barr virus (EBV), and its diagnosis is often complicated by hemophagocytic lymphohistiocytosis (HLH) that can obscure the underlying malignancy and delay therapy. We...
Shu-Tan Li, Chao Fang· Frontiers in Immunology· 0 citations
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive hematologic malignancy predominantly affecting older adults. While the CD123-directed agent tagraxofusp has improved outcomes, durable long-term survival is typically limited to patients eligible for transplant, leaving effective transplant-free...
Tia Cheunkarndee, C. Schumann, N. Pemmaraju et al.· Leukemia Research Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.